Drugs that contain Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate
1. List of Moviprep drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7169381 | SALIX PHARMS | Colon cleansing compositions and methods |
Sep, 2024
(1 year, 3 months from now) | |
| US7658914 | SALIX PHARMS | Colon cleansing compositions |
Sep, 2024
(1 year, 3 months from now) | |
Market Authorisation Date: 02 August, 2006
Treatment: NA
Dosage: FOR SOLUTION;ORAL
MOVIPREP family patents
8
United States
4
Germany
3
Spain
3
Denmark
3
Russia
3
Japan
3
Portugal
3
Slovenia
3
Australia
3
European Union
2
Hong Kong
2
Poland
2
China
2
Canada
2
Cyprus
2
United Kingdom
1
Austria
1
Turkey
1
Mexico
1
South Africa
1
Lithuania
1
Hungary
2. List of Plenvu drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10792306 | SALIX | Colonoscopy—preparation |
Mar, 2032
(8 years from now) | |
| US11529368 | SALIX | Colonoscopy—preparation |
Mar, 2032
(8 years from now) | |
| US10780112 | SALIX | Colonoscopy-preparation |
Mar, 2032
(8 years from now) | |
| US10646512 | SALIX | Colonoscopy - preparation |
Mar, 2032
(8 years from now) | |
| US9592252 | SALIX | Colonoscopy—preparation |
Aug, 2032
(9 years from now) | |
| US10918723 | SALIX | Colon cleansing compositions and methods of use |
Sep, 2033
(10 years from now) | |
| US9707297 | SALIX | Compositions |
Sep, 2033
(10 years from now) | |
| US10016504 | SALIX | Compositions |
Sep, 2033
(10 years from now) | |
| US8999313 | SALIX | Compositions |
Sep, 2033
(10 years from now) | |
| US9326969 | SALIX | Compositions |
Sep, 2033
(10 years from now) | |
Market Authorisation Date: 04 May, 2018
Treatment: For cleansing of the colon in preparation for colonoscopy in adults
Dosage: FOR SOLUTION;ORAL
PLENVU family patents
17
United States
8
European Union
7
Korea, Republic of
6
Spain
6
China
6
Singapore
6
Japan
6
Israel
6
Australia
6
South Africa
5
Denmark
5
Portugal
5
United Kingdom
4
Poland
4
Canada
4
EA
3
Malaysia
3
RS
3
Brazil
3
Ukraine
3
New Zealand
3
Croatia
3
Taiwan
3
Slovenia
3
Mexico
3
Lithuania
3
Hungary
2
Hong Kong
2
Argentina
2
ME
1
Ireland
1
India
1
San Marino
1
Cyprus
1
Netherlands
1
Finland
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic